NCT00003243View on ClinicalTrials.gov

Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 1998

Conditions
LeukemiaLymphomaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

filgrastim

BIOLOGICAL

therapeutic allogeneic lymphocytes

DRUG

cyclophosphamide

DRUG

etoposide

DRUG

pegylated liposomal doxorubicin hydrochloride

Trial Locations (1)

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00003243 - Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer | Biotech Hunter | Biotech Hunter